Search & Analyze

Glaxosmithkline Consumer Healthcare Ltd. - (Amalgamated)

10,753.650.00 (0.00%)

BSE

: ₹45,225.05 Cr
: 39.13
: —
: —
: —

Glaxosmithkline Consumer Healthcare Ltd. - (Amalgamated) (GSKCONS) share price closed at ₹10,753.65 on the BSE.

Stock Overview

Key Fundamentals

: 45,225.05 Cr₹45.23 Thousand Crore
: 274.83
: 39.13
: 10.19
: 1,055.36
: 1,710.41 Cr₹1.71 Thousand Crore
: 0.98 %
Sector
Industry: Consumer Food
: 25.93
: 0.00

Industry Comparison

Ratio	Company	Sector
	39.13	28.48
	0.00	0.12
	10.19	3.09
	2.47	2.04
	0.98 %	0.34 %
Operating Margin	23.86 %	10.32 %

Sector figures are the median of 114 listed FMCG companies.

Peer Comparison

Name
NESTLE (I) NESTLEIND	1,170.00	54.57	2,25,612.78	1.03	1,026.77	36.32%	6,788.34	20.28%	96.74
VBL VBL	395.10	44.08	1,33,642.36	0.38	658.53	14.05%	3,822.45	24.75%	19.58
BRITANIA IND BRITANNIA	4,620.00	42.15	1,11,281.15	1.96	576.38	15.68%	4,833.50	8.55%	61.39
Glaxosmithkline Consumer Healthcare Ltd. - (Amalgamated) GSKCONS	10,753.65	39.13	45,225.05	0.98					39.92
JUBL FOOD JUBLFOOD	419.30	113.13	27,667.31	0.29	69.62	4.38%	1,848.85	9.21%	22.55
HATSUN AGRO HATSUN	999.00	60.40	22,252.55	0.60	115.69	5.61%	2,897.64	19.36%	17.40
DEVYANI DEVYANI	120.75		14,887.75	0.00	8.50	36.98%	998.52	8.90%	9.97
ZYDUS WELL ZYDUSWELL	461.40	382.00	14,679.94	0.26	5.50	19.57%	153.00	8.59%	1.43

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2014-15 (Mar)	FY 2015-16 (Mar)	FY 2016-17 (Mar)	FY 2017-18 (Mar)	FY 2018-19 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	4,531.03	4,564.38	4,425.91	4,377.05	4,782.01
Less: Excise Duty	223.44	428.11	434.63	60.54
	4,307.59	4,136.27	3,991.28	4,316.52	4,782.01
EXPENDITURE :
Increase/Decrease in Stock	-39.93	-2.70	-7.66	40.98	-58.92
Raw Material Consumed	1,220.06	1,069.03	1,061.20	1,136.92	1,207.83
Power & Fuel Cost	65.22	78.66	72.31	73.43	76.79
Employee Cost	431.29	504.98	450.86	527.73	644.62
Other Manufacturing Expenses	666.02	471.71	426.44	434.39	479.22
General and Administration Expenses	286.40	427.70	428.25	452.85	445.42
Selling and Distribution Expenses	922.24	737.86	701.76	747.02	824.85
Miscellaneous Expenses	26.19	10.87	19.79	19.84	21.22
	3,577.50	3,298.11	3,152.97	3,433.16	3,641.04
Operating Profit (Excl OI)	730.08	838.16	838.31	883.36	1,140.97
	221.89	277.51	239.06	257.41	432.60
	951.97	1,115.67	1,077.37	1,140.76	1,573.57
Interest	0.74	2.28	2.78	2.03	0.78
PBDT	951.23	1,113.39	1,074.59	1,138.73	1,572.80
	62.09	57.44	64.18	64.37	60.50
Profit Before Taxation & Exceptional Items	889.14	1,055.95	1,010.42	1,074.36	1,512.29
	889.14	1,055.95	1,010.42	1,074.36	1,512.29
Provision for Tax	305.54	368.67	353.74	374.26	529.49
	583.60	687.28	656.68	700.10	982.80
Consolidated Net Profit	583.60	687.28	656.68	700.10	982.80
Adjustments to PAT	-5.02
Profit Balance B/F	852.04	1,374.55	1,710.84	2,034.80	2,397.25
Appropriations	1,430.62	2,061.83	2,367.52	2,734.91	3,380.06
Equity Dividend %	550.00%	700.00%	700.00%	750.00%	1,050.00%
	138.77	163.42	156.15	166.47	233.69
Adjusted EPS	138.77	163.42	156.15	166.47	233.69

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2014-15 (Mar)	FY 2015-16 (Mar)	FY 2016-17 (Mar)	FY 2017-18 (Mar)	FY 2018-19 (Mar)
	42.06	42.06	42.06	42.06	42.06
Total Reserves	2,070.98	2,756.65	3,080.61	3,443.06	4,052.66
Reserve excluding Revaluation Reserve	2,070.98	2,756.65	3,080.61	3,443.06	4,052.66
Revaluation reserve	0.00
	2,113.04	2,798.71	3,122.67	3,485.12	4,094.71
Secured Loans		2.07
Deferred Tax Assets / Liabilities	-104.34	-113.13	-127.80	-115.45	-113.89
Other Long Term Liabilities	9.93
Long Term Provisions	2,037.88	2,441.72	2,821.26	2,980.43	2,939.77
Total Non-Current Liabilities	1,943.47	2,330.65	2,693.46	2,864.98	2,825.87
Trade Payables	759.78	785.18	875.66	1,006.16	952.61
Other Current Liabilities	531.13	366.01	415.17	422.05	529.08
Short Term Provisions	395.14	305.47	304.79	314.38	869.01
Total Current Liabilities	1,686.04	1,456.66	1,595.62	1,742.59	2,350.70
Total Liabilities	5,742.55	6,586.02	7,411.75	8,092.69	9,271.29
Gross Block	1,059.28	569.43	629.35	650.85	696.76
Less: Accumulated Depreciation	567.54	88.16	141.93	175.32	234.69
	491.74	481.28	487.43	475.53	462.07
	42.31	51.39	49.18	35.71	12.59
Long Term Investment	0.00
Long Term Loans & Advances	1,903.02	2,289.68	2,719.65	3,011.48	2,980.73
Other Non Current Assets	0.06	6.06	7.87	5.43	6.63
Total Non-Current Assets	2,437.14	2,828.41	3,272.62	3,530.69	3,467.15
Inventories	466.25	461.62	461.14	409.42	465.47
Sundry Debtors	313.36	354.16	321.00	278.72	385.68
Cash and Bank	2,296.52	2,712.27	3,087.38	3,585.20	4,097.34
Other Current Assets	156.01	70.34	67.21	79.48	96.93
Short Term Loans and Advances	73.27	159.22	202.40	209.18	758.72
Total Current Assets	3,305.42	3,757.61	4,139.13	4,562.00	5,804.14
Net Current Assets (Including Current Investments)	1,619.37	2,300.95	2,543.51	2,819.41	3,453.43
Total Assets	5,742.55	6,586.02	7,411.75	8,092.69	9,271.29
	605.36	129.79	135.06	140.34	145.61
Total Debt	0.00	12.75	8.36	0.00	0.00
	502.44	665.48	742.51	828.70	973.65
Adjusted Book Value	502.44	665.48	742.51	828.70	973.65

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2014-15 (Mar)	FY 2015-16 (Mar)	FY 2016-17 (Mar)	FY 2017-18 (Mar)	FY 2018-19 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	889.14	1,055.95	1,010.42	1,074.36	1,512.29
Adjustment	-101.81	-183.89	-111.33	-144.59	-343.08
Changes In working Capital	120.13	53.40	124.06	260.21	1.38
Cash Flow after changes in Working Capital	907.47	925.46	1,023.14	1,189.98	1,170.58
Cash Flow from Operating Activities	611.47	573.46	602.97	723.04	671.07
Cash Flow from Investing Activities	330.69	-151.58	-602.40	-446.45	-335.06
Cash Flow from Financing Activitie	-222.15	-285.59	-361.33	-363.40	-376.80
Net Cash Inflow / Outflow	720.00	136.29	-360.75	-86.81	-40.78
Opening Cash & Cash Equivalents	205.38	925.38	1,061.67	700.91	614.10
Closing Cash & Cash Equivalent	925.38	1,061.67	700.91	614.10	573.32

Ratios

Valuation

39.13

10.19

23.97

9.07

274.83

1,055.36

Profitability

25.93

39.92

11.32

23.86

20.55

Leverage & Liquidity

0.00

2.47

1,943.07

Returns

0.98

0.55

Shareholding Pattern

Numbers in percentages

Particulars
No. of Shareholders

Mutual Funds Invested

No mutual fund holds this stock in its latest portfolio.

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date

No corporate actions data available.

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

FMCGConsumer Food

Glaxosmithkline Consumer Healthcare Ltd. - (Amalgamated) operates in the FMCG sector under the Consumer Food industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

7 members across the board and senior leadership

P Dwarakanath

Chairman

₹22.25 L

Mar '19

Navneet Saluja

Managing Director

₹11.13 Cr

Mar '19

Sangeeta Talwar

Non Executive Independent Director

₹25.00 L

Mar '19

S Madhavan

Non Executive Independent Director

₹5.50 L

Mar '19

Anup Dhingra

Whole Time Director

₹6.48 Cr

Mar '19

Shanu Saksena

Company Secretary

—

PV Bhide

Non Executive Independent Director

—

GSKCONS Latest News

News

No news found for Glaxosmithkline Consumer Healthcare Ltd. - (Amalgamated).

Glaxosmithkline Consumer Healthcare Ltd. - (Amalgamated)

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

GSKCONS Latest News

News